Page last updated: 2024-08-20

nafcillin and Gram-Positive Bacterial Infections

nafcillin has been researched along with Gram-Positive Bacterial Infections in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Raut, A; Rybak, MJ; Smith, JR; Yim, J	1
Agarwal, A; Gergits, F; Isaacson, G	1
Hegde, SS; Judice, JK; Kaniga, K; McCullough, J; Obedencio, G; Pace, J; Reyes, N; Shaw, JP; Skinner, R; Thomas, R; Vanasse, N; Wiens, T	1

Reviews

1 review(s) available for nafcillin and Gram-Positive Bacterial Infections

Article	Year
Metastatic intracranial abscesses of bronchopulmonary origin. The Pediatric infectious disease journal, 2003, Volume: 22, Issue:3 Topics: Brain Abscess; Bronchi; Bronchoscopy; Ceftriaxone; Child, Preschool; Contrast Media; Drug Therapy, Combination; Follow-Up Studies; Foreign Bodies; Foreign-Body Reaction; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Metronidazole; Nafcillin; Risk Assessment; Tomography, X-Ray Computed; Treatment Outcome	2003

Article

Year

Metastatic intracranial abscesses of bronchopulmonary origin.

The Pediatric infectious disease journal, 2003, Volume: 22, Issue:3

Topics: Brain Abscess; Bronchi; Bronchoscopy; Ceftriaxone; Child, Preschool; Contrast Media; Drug Therapy, Combination; Follow-Up Studies; Foreign Bodies; Foreign-Body Reaction; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Metronidazole; Nafcillin; Risk Assessment; Tomography, X-Ray Computed; Treatment Outcome

2003

Other Studies

2 other study(ies) available for nafcillin and Gram-Positive Bacterial Infections

Article	Year
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci	2016
Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8 Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Endpoint Determination; Female; Gram-Positive Bacterial Infections; Linezolid; Lipoglycopeptides; Methicillin Resistance; Mice; Muscle, Skeletal; Nafcillin; Neutropenia; Oxazolidinones; Protein Binding; Staphylococcal Infections; Subcutaneous Tissue; Vancomycin	2004

Article

Year

Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.

Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4

Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci

2016

Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria.

Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8

Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Endpoint Determination; Female; Gram-Positive Bacterial Infections; Linezolid; Lipoglycopeptides; Methicillin Resistance; Mice; Muscle, Skeletal; Nafcillin; Neutropenia; Oxazolidinones; Protein Binding; Staphylococcal Infections; Subcutaneous Tissue; Vancomycin

2004